EXMceuticals (STU:9OM1) EV-to-EBIT : -1.60 (As of May. 25, 2024)

EXMceuticals EV-to-EBIT Chart

EXMceuticals Annual Data
	Trend	Jun11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun17	Jun18	Jun19	Jun20
EV-to-EBIT		Get a 7-Day Free Trial					-6.87	-6.34	-10.91	-4.65	-1.74

EXMceuticals Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
EV-to-EBIT	Get a 7-Day Free Trial															-1.43	-1.74	-1.42	-1.42	-1.72

Competitive Comparison of EXMceuticals's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, EXMceuticals's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EXMceuticals's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EXMceuticals's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where EXMceuticals's EV-to-EBIT falls into.

EXMceuticals EV-to-EBIT Calculation

EXMceuticals's EV-to-EBIT for today is calculated as:

EXMceuticals's current Enterprise Value is €9.62 Mil.
EXMceuticals's EBIT for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was €-6.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EXMceuticals  (STU:9OM1) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

EXMceuticals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2021 is calculated as:

EXMceuticals's Enterprise Value for the quarter that ended in Mar. 2021 was €10.32 Mil.
EXMceuticals's EBIT for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was €-6.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EXMceuticals EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of EXMceuticals's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

EXMceuticals (STU:9OM1) Business Description